EDOC:SW:SW-Global X Telemedicine & Digital Health ETF A CHF (CHF)

ETF | Others |

Last Closing

USD 7.153

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.14 (+1.10%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.23 (+1.18%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.26 (+0.98%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.43 (+1.65%)

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-85.00 (-1.05%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+25.00 (+0.48%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-7.60 (-0.46%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+8.50 (+0.38%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.86 (+1.18%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

+1.08 (+0.99%)

USD 130,595.12B

ETFs Containing EDOC:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.70% 35% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.70% 32% F 35% F
Trailing 12 Months  
Capital Gain 4.00% 31% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.00% 28% F 32% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -6.65% 3% F 6% D-
Dividend Return -6.65% 3% F 6% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.06% 31% F 38% F
Risk Adjusted Return -55.15% 4% F 5% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.